Overview A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors Status: Not yet recruiting Trial end date: 2024-07-31 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of SHR-1921. Phase: Phase 1 Details Lead Sponsor: Atridia Pty Ltd.